Ledger.Open graph →
SEC Form D · filed May 14, 2021

Vaxess Technologies, Inc

Offering
$35.0M
Sold
$25.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Kathryn Kosuda · Cambridge, MAExec · DirectorPurnanand Sarma · Cambridge, MADirectorLivio Valenti · Cambridge, MAExecMichael Schrader · Cambridge, MAExec · DirectorAnn Dewitt · Cambridge, MADirectorLynda Tussey · Cambridge, MAExecJonathan Kluge · Cambridge, MAExecTed Hibben · Cambridge, MAExecPeter Kolchinsky · Boston, MADirectorScott K. Bessent · Greenwich, CTExecJonathan G. Shulkin · Chicago, ILExecMichael Blue · Seattle, WAExecNewton E. Mack · Portland, ORExecWendy E. Holley · St. Helier, Y9Exec · DirectorClea E. Kolster · Portland, ORDirectorPeter E. Joseph · Portland, ORDirectorKeith Manchester · Palo Alto, CAExec · DirectorJulia Hu · Mountain View, CAExec · DirectorChristina Mcguire · London, United KingdomExecHelen Wetherall · St Helier, Y9ExecAnthony R. Sozio · New York, NYExec · DirectorJanine Aeroporos · Los Angeles, CAExecMark Ronay · PORTLAND, ORDirectorRonald J. Masciantonio · Philadelphia, PAExecLloyd T. Rochford · Rancho Mirage, CADirectorPeter Kolchinsky · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗